William Demers
Director of Finance/CFO chez POINT Biopharma, Inc. (United States)
Profil
William Demers is currently the Chief Financial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he was the Chief Financial Officer at Contract Pharmaceuticals Ltd.
and AgMedica Bioscience, Inc. He also worked as a Senior Assurance Partner at Ernst & Young LLP from 2014 to 2018.
In terms of education, he received an undergraduate degree from Wilfrid Laurier University.
Additionally, he is currently serving as the Chief Financial Officer & Secretary at POINT Biopharma Global, Inc. from 2021 to 2023.
Postes actifs de William Demers
| Sociétés | Poste | Début |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Director of Finance/CFO | 01/08/2020 |
Anciens postes connus de William Demers
| Sociétés | Poste | Fin |
|---|---|---|
| POIT BIOP | Director of Finance/CFO | 27/12/2023 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2018 |
Formation de William Demers
| Wilfrid Laurier University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
